CABS Seminar, Saturday Afternoon, Dec. 10, 2011
Topic: “Clinical Development and Beyond”
Date and Time: Dec. 10, 2011, 1:00-4:30 pm
12:30 pm - 1:00 pm Registration and networking
1:00 pm - 1:40 pm Pharmacoeconomics and Pharmacogenomics in Clinical Trials
Ullrich Schwertschlag, MD, Medical Consultant at Theravance and CMO at Attogen
1:40 - 2:20 pm Dose selection and PK/PD for Oncology Trials
Soo-Peang Khor, Ph.D., Khor Pharmaceutical Consulting, formerly VP of Oncology at Geron
2:20 - 2:40 pm Coffee Break
2:40 - 3:20 pm Therapeutic Protein Drug Interactions with an Emphasis on Antibody Drug Conjugates
Dan Lu, Ph.D., Associate Scientist, Department of Clinical pharmacology, Genentech
3:20 - 4:00 pm Evolving Models of Pharmaceutical Marketing and Sales
Xi Wang, Ph.D., Clinical Science Consultant, Northwest District, Boehringer Ingelheim Inc.
4:00 - 5:00 pm Q&A and networking
Register at http://www.cabsweb.org/CABSweb/feventslist.jsp?id=167
Registration Requirement: Online registration is strongly encouraged.
Online registration: Onsite registration:
Active members: $1 Non-members: $5 Active members: $5 Non-members: $10
Location: Syracuse Room, Crowne Plaza Hotel, 1221 Chess Dr., Foster City, CA 94404
Topic Description:
The CABS Science Committee is proud to present the last of the 2011 workshop series, featuring rational clinical development and evolving business models for sales and marketing. Our featured speakers will share their experiences and case studies to illustrate recent developments in clinical research and post-approval sales and marketing.
